(Q46790735)

English

Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

1 reference

based on heuristic

inferred from title

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

8

object named as

R Storb

1 reference

Europe PubMed Central

25 December 2017

Hans Joachim Deeg

9

object named as

H J Deeg

1 reference

Europe PubMed Central

25 December 2017

author name string

B L Scott

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

B M Sandmaier

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

B Storer

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

M B Maris

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

M L Sorror

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

D G Maloney

6

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

T R Chauncey

7

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

publication date

1 January 2006

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

20

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

128-135

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404010

0 references

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404010

21 January 2018

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404010

21 January 2018

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404010

21 January 2018

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404010

21 January 2018

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404010

21 January 2018

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404010

21 January 2018

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404010

21 January 2018

Graft-versus-leukemia reactions in allogeneic chimeras

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404010

21 January 2018

Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404010

21 January 2018

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404010

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404010

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16270037

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46790735&oldid=2132227787"